Eli Lilly

States slow to cover GLP-1s for weight loss
Axios
Wed, 11/6/24 - 11:37 am
Medicaid
GLP-1 agonists
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
Lilly shares fall as obesity drug sales miss forecasts
BioPharma Dive
Wed, 10/30/24 - 11:52 am
Eli Lilly
earnings
obesity
Zepbound
Mounjaro
Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's
First Word Pharma
Mon, 10/28/24 - 06:24 pm
Eli Lilly
JNJ
Crohn's Disease
FDA
clinical trials
Tremfya
Omvoh
J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups
Fierce Pharma
Fri, 10/25/24 - 11:43 am
JNJ
Eli Lilly
Tremfya
immunology
plaque psoriasis
Ebglyss
atopic dermatits
How Lilly is building a brand people trust
Medical Marketing and Media
Thu, 10/24/24 - 08:20 pm
Eli Lilly
branding
reputation
public trust
Weight-loss drugs didn't curb health costs within two years
Reuters
Thu, 10/24/24 - 11:11 am
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
obesity
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Reuters
Thu, 10/24/24 - 09:53 am
Eli Lilly
Mounjaro
Novo Nordisk
Denmark
obesity
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
Pharmaphorum
Wed, 10/23/24 - 11:26 am
Eli Lilly
Alzheimer's disease
Kisunla
UK
NHS
NICE
Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing'
Fierce Pharma
Tue, 10/22/24 - 11:32 pm
Senate
Pfizer
Eli Lilly
telehealth
DTC
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Mon, 10/21/24 - 09:37 am
FDA
GLP-1 agonists
Ozempic
Wegovy
Novo Nordisk
drug shortages
Eli Lilly
Zepbound
On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study
Fierce Pharma
Tue, 10/15/24 - 10:15 am
Eli Lilly
Crohn's Disease
Omvoh
clinical trials
JNJ
Stelara
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
BioPharma Dive
Mon, 10/14/24 - 11:17 pm
Eli Lilly
drug shortages
Zebound
Mounjaro
FDA
Lilly picks UK for first European Gateway Lab as part of $364M investment plan
Fierce Biotech
Mon, 10/14/24 - 10:28 am
Eli Lilly
Gateway Labs
incubators
Europe
FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Reuters
Sun, 10/13/24 - 11:33 am
FDA
Eli Lilly
compounded drugs
drug shortages
obesity drugs
tirzepatide
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Novo Nordisk
Eli Lilly
obesity
Zebound
Wegovy
CagriSema
Amgen
MariTide
oforglipron
Veru
enobosarm
nimacimab
Skye Bioscience
Lilly names Mount Sinai scientist as first chief AI officer
BioPharma Dive
Wed, 10/9/24 - 09:05 pm
Eli Lilly
artificial intelligence
Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases
BioSpace
Wed, 10/9/24 - 09:46 am
Insitro
Eli Lilly
siRNA
MASH
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
R&D
obesity
weight loss
Novo Nordisk
Eli Lilly
Roche
Boehringer Ingelheim
Lilly's weight-loss drug removed from FDA's shortage list
Reuters
Thu, 10/3/24 - 10:06 am
Eli Lilly
FDA
drug shortages
Mounjaro
High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project
Fierce Pharma
Wed, 10/2/24 - 11:27 am
Eli Lilly
JNJ
medicine foundry
drug manufacturing

Pages